Intravenous Ibuprofen Market latest Report with Forecast to 2017 ? 2022Posted by rohan on May 29th, 2018 Global Intravenous Ibuprofen Market was worth USD 5.72 billion in 2017 and estimated to be growing at a CAGR of 20.0%, to reach USD 14.23 billion by 2022. Ibuprofen is a Non steroidal anti-Inflammatory drug used to treat pain and fever which can be causative of a disease, trauma or any major operation. In an intravenous form, the drug has a faster onset of action as compared to other forms. IV Ibuprofen is used to manage acute and post-operative pain. Browse market data tables and in-depth TOC of the Intravenous Ibuprofen Market to 2022 @ https://www.marketdataforecast.com/market-reports/intravenous-ibuprofen-market-6729/ Due to its faster onset of action and fast results, the market is expected to grow at a rapid rate during the forecast period. As it has been approved for paediatric use, the market is further expected to propel. Due to increased incidence of cardiovascular diseases, cancer and fever coupled with shifting trend to non-opoid drugs is further driving the market growth. However, the side effects associated with the use of ibuprofen and the lengthy approval processes are hampering the market growth. Free sample of the report is available @ https://www.marketdataforecast.com/market-reports/intravenous-ibuprofen-market-6729/request-sample The market for Intravenous Ibuprofen is broadly categorized into age group and indication. By age group the market is divided into adults and paediatrics. Adults are the major consumer base for intravenous ibuprofen. The paediatric segment is expected to grow at a substantial rate. By indication the market is further classified into fever and pain/inflammatory. Fever is projected to be the fastest growing segment. On the basis of geography, the market is analysed under various regions namely North America, Europe, Asia-Pacific and Rest of the World. The Intravenous Ibuprofen market was dominated by North America. Asia Pacific is expected to grow at a high CAGR. Some of the major companies dominating the market, by their products and services include Cumberland Pharmaceuticals Inc., Alveda Pharmaceuticals, Inc., CSL Limited, Sandor Medicaids Pvt Ltd., Germin MED, Grifols S.A., Harbin Gloria Pharmaceuticals Co., Ltd., Al Nabeel International Ltd., PT. Soho Industri Pharmasi, and Laboratorios Valmorca, C.A. The scope of the report provides:
Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest. About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions. Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206
Like it? Share it!More by this author |